Andreeff M , R-Y W, Davis E, Jacamo R, Ruvolo P, McQueen T, Huang X, Battula VL, Chen Y, Majumdar S, Benito JM, Zeng Z, Benton C, Carter B, Mu H, Ma W, Ruvolo V, Hodgson L, Konoplev S, Pan R, Somanchi A, Strunck D, Zhang Q, Kornblau SM, Kantarjian H, Marcucci G, Garzon R, Zuber J, Lowe S, Croce C, Konopleva M
These FGIDs have recently been renamed to disorders of the gut-brain axis (DGBIs)
# IGF-1 LR3 vs HGH: Dosing, Use Cases, and Safety Monitoring IGF-1 LR3 and HGH (somatropin) are frequently discussed together, but they are not interchangeable
Regulation of the human SLC25A20 expression by peroxisome proliferator-activated receptor alpha in human hepatoblastoma cells